Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

XERS

Xeris Biopharma (XERS)

Xeris Biopharma Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XERS
DateTimeSourceHeadlineSymbolCompany
03/07/20253:11PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XERSXeris Biopharma Holdings Inc
03/06/20253:07PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:XERSXeris Biopharma Holdings Inc
03/06/20256:21AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
02/27/20256:00AMBusiness WireXeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025NASDAQ:XERSXeris Biopharma Holdings Inc
02/24/20257:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
02/24/20257:00AMBusiness WireXeris Appoints Anh Nguyen, MD, MBA as Chief Medical OfficerNASDAQ:XERSXeris Biopharma Holdings Inc
02/05/20257:00AMBusiness WireXeris to Participate in Upcoming Investor ConferencesNASDAQ:XERSXeris Biopharma Holdings Inc
02/03/20256:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XERSXeris Biopharma Holdings Inc
02/03/20256:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XERSXeris Biopharma Holdings Inc
01/21/20258:00AMPR Newswire (US)The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and AwarenessNASDAQ:XERSXeris Biopharma Holdings Inc
01/10/20256:17AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
01/10/20256:00AMBusiness WireXeris Expects to Exceed Full-Year 2024 Financial GuidanceNASDAQ:XERSXeris Biopharma Holdings Inc
01/07/20253:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XERSXeris Biopharma Holdings Inc
01/07/20253:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XERSXeris Biopharma Holdings Inc
01/06/20253:15PMBusiness WireXeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:XERSXeris Biopharma Holdings Inc
11/26/20246:00AMBusiness WireXeris to Participate in Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:XERSXeris Biopharma Holdings Inc
11/08/20243:02PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XERSXeris Biopharma Holdings Inc
11/08/20246:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
11/08/20246:00AMBusiness WireXeris Biopharma Reports Third Quarter 2024 Financial ResultsNASDAQ:XERSXeris Biopharma Holdings Inc
10/31/20247:00AMBusiness WireXeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024NASDAQ:XERSXeris Biopharma Holdings Inc
10/04/20243:05PMBusiness WireXeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:XERSXeris Biopharma Holdings Inc
08/22/20246:00AMBusiness WireXeris to Participate in Upcoming Investor ConferencesNASDAQ:XERSXeris Biopharma Holdings Inc
08/09/20243:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XERSXeris Biopharma Holdings Inc
08/08/20243:27PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XERSXeris Biopharma Holdings Inc
08/08/20246:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
08/08/20246:00AMBusiness WireXeris Biopharma Reports Second Quarter 2024 Financial ResultsNASDAQ:XERSXeris Biopharma Holdings Inc
08/02/20244:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XERSXeris Biopharma Holdings Inc
08/02/20244:16PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XERSXeris Biopharma Holdings Inc
08/02/20243:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
07/25/20246:00AMBusiness WireXeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:XERSXeris Biopharma Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:XERS